Welcome to Our Medtech Talk Podcast Channel

Too often we define the Medtech sector by the number of dollars raised, IPOs helped or companies sold. But the focus neglects the very foundation of the sector - the People. Join the Medtech Talk Podcast each week to hear from entrepreneurs, investors and executives who spend their days developing the tools that make sick people well and health care more efficient.

Zenflow CEO Damiano Shares Start-up’s Origins, Success in Building the Right Series A Syndicate

February 27, 2018

The Stanford Biodesign program created another promising start-up in Zenflow. Co-founder and CEO Nick Damiano explains how the program’s fellows identified the opportunity in BPH and found the right tech to excite investors. Zenflow drew some early capital from unusual sources before embarking on an exhausting pursuit of the right Series A syndicate. Damiano shares some advice for other capital-hungry start-ups. Overview: Great to see a monster Medtech Series A! Surprises: Zenflow is working out of some offices with great karma. Regrets: None. I’m feeling good about this one. I could have asked about the broader team.

Nick Damiano

Co-Founder & CEO

ZENFLOW

Nick Damiano is an experienced healthcare entrepreneur who started his career as an engineer before co-founding and leading several startup companies. He is currently Co-Founder & CEO of Zenflow, a clinical-stage medical device company developing an office-based therapy for BPH (enlarged prostate). Nick co-founded Zenflow along with Shreya Mehta out of the Stanford Biodesign fellowship in 2014. From 2013-14, he spent a year as the Lucile Packard Fellow in the Biodesign program. Nick was also Co-Founder & CTO of Nurep, a digital health company developing a mobile platform for remote surgical support that is currently in commercial use with leading medical device companies. Before Nurep, he worked in R&D engineering roles for several medtech startups and earned his MS/BS in Management Science & Engineering from Stanford University.